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Objectives The goal of this study was to compare transesophageal echocardiography (TEE) and intracardiac echocardiogra-
phy (ICE) for the diagnosis of cardiac device–related endocarditis (CDI).
Background The diagnosis of infective endocarditis (IE) was established by using the modified Duke criteria based mainly on
echocardiography and blood culture results. No previous studies have compared ICE with TEE for the diagnosis of IE.
Methods We prospectively enrolled 162 patients (age 72  11 years; 125 male) who underwent transvenous lead extrac-
tion: 152 with CDI and 10 with lead malfunction (control group). Using the modified Duke criteria, we divided the
patients with infection into 3 groups: 44 with a “definite” diagnosis of IE (group 1), 52 with a “possible” diagno-
sis of IE (group 2), and 56 with a “rejected” diagnosis of IE (group 3). TEE and ICE were performed before the
procedure.
Results In group 1, ICE identified intracardiac masses (ICM) in all 44 patients; TEE identified ICM in 32 patients (73%). In
group 2, 6 patients (11%) had ICE and TEE both positive for ICM, 8 patients (15%) had a negative TEE but a posi-
tive ICE, and 38 patients (73%) had ICE and TEE both negative. In group 3, 2 patients (3%) had ICM both at ICE
and TEE, 1 patient (2%) had an ICM at ICE and a negative TEE, and 53 patients (95%) had no ICM at ICE and
TEE. ICE and TEE were both negative in the control group.
Conclusions ICE represents a useful technique for the diagnosis of ICM, thus providing improved imaging of right-sided leads
and increasing the diagnostic yield compared with TEE. (J Am Coll Cardiol 2013;61:1398–405) © 2013 by the
American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.12.041The incidence of infection of cardiac rhythm devices has
been reported in 0.8% to 19.9% of patients with a previous
cardiac device implantation (1–4). The complete removal of
all hardware is the recommended treatment for patients
with established cardiovascular implantable electronic de-
vice infection (5). The main indications for lead removal
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April 2, 2013:1398–405 Echocardiography in Lead Endocarditisimplantable electronic device–related endocarditis ranges
from 20% to 25% of all device-related infections, as
described in recent studies (6 – 8).
In clinical practice, the diagnosis of infective endocarditis
(IE) is established by using the modified Duke criteria based
on clinical and imaging diagnosis; transesophageal echocar-
diography (TEE) may be a useful tool in this clinical
setting (9,10). However, the diagnosis of IE can be
particularly challenging in cases with prosthetic valves or
pacemaker leads, even with the use of TEE (11–13). These
structures can cause acoustic shadowing and reverberation
artifacts, limiting the detection of infective vegetations. The
main limitation is the inability to obtain high-resolution
images due to the large distance between the transesopha-
geal probe and the right ventricle (far-field limitation) (14).
Because of the increased morbidity and mortality due to a
delayed diagnosis of IE, the current European Society of
Cardiology (ESC) (9) and American Heart Association
(AHA) (10) guidelines recommend repeat TEE examina-
tions in cases of high clinical suspicion of IE if any initial
echocardiographic findings are negative. Moreover, the
original or modified Duke criteria do not specifically address
the diagnosis of cardiac device–related IE (9,10). As pro-
posed by Sohail et al. (2,7), the presence of lead vegetation
and clinical evidence of LDI could be considered major
criteria for the diagnosis of cardiac device–related IE.
Recently, intracardiac echocardiography (ICE) was re-
ported to be useful for the diagnosis of intracardiac vegeta-
tion when there is a high clinical suspicion of IE and a
negative TEE (15,16), but these 2 diagnostic tools have not
yet been directly compared. We designed this prospective
observational study in patients subjected to transvenous lead
extraction to test initial findings regarding the accuracy of
ICE compared with standard TEE in the diagnosis of
intracardiac masses (ICM).
Methods
Study population and procedural management. We pro-
spectively enrolled 162 consecutive patients (mean age 72
11 years; 125 male) referred to our center from January 2006
to January 2012 for transvenous lead extraction: 152 patients
with cardiac device–related infection and 10 patients with
lead malfunction (control group). At admission, 68 patients
(42%) had an LDI, 63 patients (39%) had LDI and sepsis,
and 21 patients (13%) had a diagnosis of sepsis with no
evidence of LDI. All clinical data were accurately collected
for all patients. Collected data included previous hospital
admissions and device implantation, cardiovascular risk
factors, pharmacological therapy, clinical presentation re-
lated to device infection, echocardiographic parameters, and
all procedural data. Blood, swab, and lead-tip cultures were
obtained in a sterile manner (5).
All patients underwent transvenous lead extraction, as
described previously (17), following the latest Heart
Rhythm Society consensus document recommendations (5),and no surgical lead extractions
were performed in these patients.
TEE was performed before
transvenous lead extraction on
the same day, while ICE was
performed right before starting
the procedure and ICE monitor-
ing was continued throughout
the procedure. Offline TEE and
ICE images were presented in-
dependently and in randomized
order to 2 expert interpreters.
The study was approved by the
institutional review board, and all
patients gave their written in-
formed consent.
Definitions of IE. IE was defined according to the mod-
ified Duke criteria, following the current guidelines (9,10).
A diagnosis of “definite” IE was defined as the presence of
either 2 major criteria or 1 major and 3 minor criteria (group
1 patients); a diagnosis of “possible” IE was defined as the
presence of either 1 major and 1 minor criteria or 3 minor
criteria (group 2 patients); a diagnosis of IE was “rejected”
in patients who did not meet the aforementioned criteria for
IE (group 3 patients). Moreover, as proposed by Sohail et al.
(2,7), the diagnosis of definite cardiac device–related IE was
obtained in patients with echocardiographic evidence of lead
vegetations (without using ICE for the diagnosis of IE) and
clinical evidence of LDI.
Finally, due to the lack of a gold standard for the
diagnosis of IE, we used both the different criteria (Duke
and Sohail) for the diagnosis of IE, to extract from our
population with infection a larger number of patients with a
definite diagnosis of IE.
Transesophageal echocardiography. TEE was performed
in all patients in a fasting state for more than 4 h (18). We
assessed TEE by using a 5-MHz phased multiplane probe
transducer (Philips, iE 33, Andover, Massachusetts)
mounted on a flexible monoplane probe connected to a
Toshiba Medical System (Artida 2D, Toshiba Medical
System, Tokyo, Japan). The pacemaker/defibrillator leads
and tricuspid valve leaflets were imaged from the 4-chamber
projection, frontal long-axis view of the coronary sinus, and
gastric short-axis view. ICM were defined as discrete,
echogenic, floating masses found on a valve, lead, or
endocardial surface.
Intracardiac echocardiography. ICE (19,20) was per-
formed by using a 10-F probe AcuNav (Siemens Medical
Solutions distributed by Biosense Webster, Diamond Bar,
California) or 10-F probe SoundStar (Biosense Webster),
advanced through a femoral vein percutaneous access in the
setting of the extraction procedure, which was performed on
the same day as the TEE. These catheters were equipped
with a linear phased array multifrequency (5.5 to 10 MHz)
transducer, and this was connected to a Sequoia system
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ESC  European Society of
Cardiology
ICE  intracardiac
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IE  infective endocarditis
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echocardiography(Acuson Corporation, Mountain View, California). The
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overview the leads along the right chambers; it was succes-
sively advanced in the right atrium and rotated to visualize
all the atrial lead segments including the appendage. It was
then advanced in the superior vena cava and brachiocephalic
vein, and finally it was curved and advanced into the right
ventricle for a better visualization of the lead segments
localized under the tricuspid valve plane and in the ventricle.
ICM suggestive for vegetation were defined as discrete,
echogenic, floating masses found on a valve, lead, or
endocardial surface. Moreover, ICE was used during the
extraction procedure for the identification of procedure-
related complications.
Statistical analysis. The homogeneity of variances was as-
sessed by using the Levene test. All variables had a normal
distribution, as assessed according to the Kolmogorov-Smirnov
test, and were compared by using the unpaired Student t test.
The Fisher exact test was used to compare categorical variables.
Correlations between data were calculated by using the Pear-
son and Spearman correlation coefficient.
Data are reported as mean SD or proportions. A 2-tailed
p value 0.05 was considered statistically significant. These
data were analyzed by using SPSS version 17.0 (SPSS Italia,
Inc., Florence, Italy). A Bland-Altman plot was used to
analyze the agreement between TEE and ICE methods in
evaluation of the maximum length of ICM. The Bland-
Altman plot was calculated by using MedCalc 12.1.4 (Med-
Calc Software, Ostend, Belgium).
Results
Study population and procedural data. Patients’ charac-
teristics are reported in Table 1. In 96 patients (60%), the
implanted device was a pacemaker (15 of 96 [16%] single
lead atrial-triggered ventricular pacemaker; 58 of 96 [60%]
dual-chamber; 14 of 96 [15%] biventricular; 9 of 96 [9%]
VDD); in the remaining 66 patients (40%), the device was
an implantable cardioverter-defibrillator (22 of 66 [33%]
single-chamber; 14 of 66 [21%] dual-chamber; 30 of 66
[46%] biventricular). In the group of patients with infection,
78 patients (51%) had fever present at admission, and 133
patients (88%) were already receiving antimicrobial prophy-
laxis before admission because of fever or clinical evidence
of LDI.
In terms of the patients with cardiac devicerelated
infection, 44 patients (29%) with a definite diagnosis of IE
were included in group 1; 52 patients (34%) with a possible
diagnosis of IE were included in group 2; and 56 patients
(37%) without a diagnosis of IE were included in group 3.
Microbiological data. Bacteriological data regarding the
152 patients with infection are summarized in Table 2.
Blood culture results were positive in 52 patients (34%),
swab culture results were positive in 115 patients (75%), and
lead-tip culture results were positive in 80 patients (53%).
Coagulase-negative staphylococci and Staphylococcus aureus
were the most common bacteria in positive blood cultureresults (26 patients [50%] and 16 patients [31%], respec-
tively) and in positive swab culture results (70 patients
[60%] and 66 patients [57%]), followed by Gram-negative
bacilli (9 patients [17%] in blood culture and 22 patients
[19%] in swab culture) and fungi (2 patients [4%] and 2
patients [2%] in blood culture and swab culture). The most
common microorganism isolated from lead-tip cultures was
coagulase-negative staphylococci (38 patients [47%]), fol-
lowed by other Gram-positive bacilli (24 patients [30%]),
Gram-negative bacilli (20 patients [25%]), and S aureus (11
Clinical Characteristics of the 162 Study PatientsTable 1 Clinical Characteristics of the 162 Study Patients
Male 125 (77)
Mean age (yrs) 72 11
Transvenous lead placement indication
Sinus node dysfunction 39 (24)
Atrioventricular block 43 (26)
Primary prevention of sudden death 16 (10)
Secondary prevention of sudden death 20 (12)
CRT-D/P 44 (28)
Type of device
Pacemaker 82 (51)
Implantable cardioverter-defibrillator 36 (22)
CRT-P 14 (9)
CRT-D 30 (18)
Transvenous lead extraction indication
Local device infection 68 (42)
Local device infection and sepsis 63 (39)
Sepsis 21 (13)
No. of device-related procedures before extraction
First implantation 80 (49)
3 procedures 44 (27)
3 procedures 38 (24)
Comorbidity
Heart failure 58 (34)
Heart failure with EF 30% 30 (18)
Diabetes 55 (34)
Hypertension 126 (78)
Creatinine clearance 60 ml/min/1.73 m2 92 (57)
Hemodialysis 7 (4)
Coronary artery disease 60 (37)
Coronary artery disease with EF 30% 19 (12)
Valvular prosthesis 12 (7)
Chronic obstructive pulmonary disease 42 (26)
Left ventricular ejection fraction 44 14
Medical therapy
Angiotensin-converting enzyme inhibitors 76 (47)
Angiotensin II receptor blockers 22 (14)
Beta-blockers 100 (62)
Antiaggregants 92 (57)
Diuretics 64 (39)
Statins 90 (56)
Antiarrhythmic therapy 25 (15)
Oral anticoagulant therapy 47 (29)
Values are n (%) or mean  SD.
CRT-D/P  cardiac resynchronization therapy with/without defibrillator backup; EF  ejection
raction.patients [14%]).
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April 2, 2013:1398–405 Echocardiography in Lead EndocarditisEchocardiographic data. The Levene test confirmed the
homogeneity of our study population (p  0.21). In group
(definite IE), ICE identified ICM in all 44 patients
100%), whereas TEE identified ICM in 32 patients (73%).
n group 2 (possible IE), 6 patients (11%) had ICE and
EE both positive for ICM, 8 patients (15%) had a
egative TEE but an ICE finding of ICM, and 38 patients
73%) had ICE and TEE both negative for ICM (p 
0.001). In group 3 (rejected IE), 2 patients (3%) had ICM
both at ICE and TEE, 1 patient (2%) had ICM at ICE but
not at TEE, and 53 patients (95%) had no ICM at both
ICE and TEE (p  0.02) (Table 3). ICE and TEE were
oth negative for ICM in the group of patients with lead
alfunction (control group).
Furthermore, by using both the modified Duke and
ohail criteria, we extracted from the population with
nfection a larger number of patients with a definite diag-
osis of IE (58 patients [38%]). In this group, ICE still
dentified the presence of ICM in all 58 patients (100%),
Microbiological Data of the152 Patients With Infec ionTable 2 Microbiol gical Data of the152 Patients With Infection
Positive blood culture result 52 (34)
Polymicrobial 1 (2)
Staphylococcus aureus 16 (31)
Coagulase-negative staphylococci 26 (50)
Other Gram-positive 2 (4)
Gram-negative 9 (17)
Fungal 2 (4)
Positive swab culture result 115 (75)
Polymicrobial 56 (49)
Staphylococcus aureus 66 (57)
Coagulase-negative staphylococci 70 (60)
Other Gram-positive 6 (5)
Gram-negative 22 (19)
Fungal 2 (2)
Positive lead-tip culture result 80 (53)
Polymicrobial 7 (9)
Staphylococcus aureus 11 (14)
Coagulase-negative staphylococci 38 (47)
Other Gram-positive 24 (30)
Gram-negative 20 (25)
Fungal 7 (9)
Values are n (%).
Echocardiographic DataRelated to the Duke and Sohail CriteriaTable 3 Echo ardiograp ic DataRelated to the Duke and Sohail Criteria
Criteria
TEE ICE
Negative Positive Negative Positive
Duke definite 12 (27) 32 (73) 0 44 (100)
Duke possible 46 (88) 6 (12) 38 (73) 14 (27)
Duke rejected 54 (96) 2 (4) 53 (95) 3 (5)
Duke definite
and Sohail
20 (35) 38 (65) 0 58 (100)Values are n (%).
TEE  transesophageal echocardiography; ICE  intracardiac echocardiography.hereas TEE identified the presence of ICM in 38 patients
65%) (Figs. 1A and 1B, Online Videos 1A and and 1B).
Moreover, among the 20 patients with negative TEE but
n ICE finding of ICM, 16 (80%) had ICM on the
entricular lead in the tricuspid valve plane in 3 patients
Figs. 2A, 2B, and 2C, Online Videos 2A and 2B); 2 patients
10%) had ICM on the atrial portion of the ventricular lead,
lso involving the tricuspid valve; 1 patient (5%) had ICM on
he ventricular lead within the right ventricle; and 1 patient
5%) had ICM on the atrial lead (Table 4).
In all 3 groups of patients with infection, ICE identified
arger ICM compared with TEE (mean maximum length 16
mm vs. 11.5  7 mm, respectively; p  0.02) (Fig. 3A), with
precise assessment of filamentous masses (Online Videos
3A, 3B, 3C, and 3D). The mean maximum length of ICM
identified at ICE was lower in the group with negative TEE
compared with the group with positive TEE (8  3 mm vs.
20  9 mm, respectively; p  0.001) (Fig. 3B). Further-
Figure 1 TEE Negative for ICM and
Ventricular Lead Visualized by ICE
Biplane transesophageal echocardiography (TEE) negative result for intracar-
diac masses (ICM) in a patient with a diagnosis of infective endocarditis
according to both modified Duke and Sohail criteria. (B) Evidence of an
echodense mass attached to the atrial portion of the lead, not visible at TEE.
ICE  intracardiac echocardiography. See also Online Videos 1A and 1B.more, no significant differences were found among the 3
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ICM identified at ICE (17.6 10 mm in group 1; 11 7 mm
in group 2; 15.7  7.5 mm in group 3; p  0.09).
A statistically significant correlation was found between
Figure 2 Detection of Filamentous
Masses on Ventricular Lead by ICE
(A and B) Biplane TEE showing a ventricular lead without ICM in a patient with
possible diagnosis of infective endocarditis according to the modified Duke cri-
teria. (C) Evidence of filamentous masses attached on atrioventricular portion
of the lead, not visible at TEE. Abbreviations as in Figure 1. See also Online
Videos 2A and 2B.the maximum length of ICM values assessed by TEE and aICE (r 0.95; p 0.001). The Bland-Altman plot showed
agreement between TEE and ICE methods in the evalua-
tion of the maximum length of ICM, as reported in Figure 4.
Considering TEE as a gold standard for the diagnosis of
ICM, ICE had a sensitivity of 100%, a specificity of 82.8%,
a positive predictive value of 65.6%, and a negative predic-
tive value of 100%.
In our study population, no lead-related masses were
found in the superior vena cava or brachiocephalic vein.
Regarding the procedure-related complications, ICE was
also able to identify mild pericardial effusions in 2 (1.2%) of
152 patients after lead extraction, without the need for
drainage.
Discussion
In this study, we directly compared for the first time the
diagnostic yield of ICE versus TEE in the detection of
ICM suggestive for vegetation in patients undergoing lead
extraction for cardiovascular implanted electronic device–
related infection. The main findings of our feasibility study
are: 1) ICE shows high diagnostic accuracy in the detection
of ICM among patients with a definite diagnosis of cardiac
device–related IE; 2) in patients with a clinical suspicion of
device-related IE undergoing transvenous lead extraction,
ICE provides a significantly higher diagnostic power for the
detection of ICM compared with TEE; 3) in the group of
patients with a high risk of device-related IE according to
the modified Duke criteria and the new, not standardized,
Sohail criteria, ICE was still able to successfully identify
more patients with ICM compared with TEE; and 4) the
Localization and Dimension of Intracardiac Massesin P tients With Positive ICE a d Negative TEETable 4 Localization a d Dimension of Intracardiac Massesin Patients With Positive ICE and Negative TEE
Case #
Maximum
Length (mm)
Vegetation Localization
on Lead Valvular Endocarditis
1 15 VL-TV plane —
2 15 VL-TV plane —
3 10 AL-A tract —
4 12 VL-TV plane —
5 11 VL-A tract Tricuspid
6 10 VL- V tract —
7 4 VL-TV plane Tricuspid
8 8 VL-TV plane Tricuspid
9 7 VL-TV plane —
10 9 VL-A tract Tricuspid
11 7 VL-TV plane Tricuspid
12 6 VL- TV plane  V tract —
13 8 VL-TV plane —
14 6 VL-TV plane —
15 8 VL-TV plane —
16 6 VL-TV plane —
17 6 VL-TV plane —
18 4 VL-TV plane —
19 5 VL-TV plane —
20 8 VL-TV plane —A  atrial; AL  atrial lead; TV  tricuspid valve; V  ventricular; VL  ventricular lead; other
bbreviations as in Table 3.
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April 2, 2013:1398–405 Echocardiography in Lead Endocarditissize of ICM measured at ICE was directly correlated to the
size at TEE, although ICE was able to identify significantly
larger ICM compared with TEE.
TEE plays a major role in the diagnosis of IE, as reported by
the current ESC and AHA guidelines (9,10), and most studies
regarding lead extraction for cardiac rhythm management
device infection use this method for the diagnosis of intracar-
diac vegetations (4,6,8,17). However, atypical or doubtful
results have been obtained by using this method, particularly in
the early stage of the disease and in patients with intracardiac
devices (11,14). In particular, TEE sensitivity for the diagnosis
of intracardiac vegetations is suboptimal because a false-
negative result on echocardiogram may be observed in about
15% of patients (9). The most frequent explanations for a
negative TEE are small intracardiac vegetations, vegetations
Figure 3 Length of ICM Measured by ICE and TEE
(A) Average maximum length of ICM measured by ICE and by TEE. (B) Maximum leng
and in patients with ICM both at ICE and TEE (ICE/TEE group). Abbreviations a
Figure 4 Bland-Altman Plot of Differences in the
Maximum Length of ICM Obtained by TEE and ICE
The y-axis shows the differences between the maximum length of ICM mea-
sured by TEE and ICE. The x-axis signifies the average of the maximum length
of ICM measured by TEE and ICE. Abbreviations as in Figures 1 and 2.localized on cardiac valves with severe lesions (e.g., mitral valve
prolapse and degenerative lesions), nonfloating and/or atypi-
cally located ICM, an early stage of the disease when vegeta-
tions are not yet present, and the presence of prosthetic valves
or cardiac device leads (9–14). In particular, with regard to
prosthetic valves and cardiac device leads, these structures may
cause acoustic shadowing and reverberation artifact, which can
limit the detection of vegetations (11–13). Moreover, due to
the large distance between the echocardiographic probe and
the tricuspid valve plane (far-field limitation), TEE may
provide limited information and not visualize all tricuspid valve
leaflets simultaneously (12–14).
In our population, TEE failed to detect ICM when they
were located on the right ventricle lead crossing the tricus-
pid valve. Several studies have reported suboptimal assess-
ment of pacemaker leads and tricuspid valve with TEE due
to their anterior location within the heart, far from the TEE
transducer (11–15). In these cases, ICE may provide better
imaging of right-sided structures prosthetic devices (16).
The current ESC and AHA guidelines suggest perform-
ing TEE for the diagnosis of IE due to its lower costs and
feasibility (9,10), but our data showed that ICE, although
an invasive tool, may reach a higher diagnostic yield, thus
representing a valid option for overcoming some limitations
linked to TEE. In fact, we found that ICE could detect
vegetations in a larger number of high-risk patients com-
pared with TEE, as well as when IE was suspected on the
basis of extended criteria (including clinical and echocardio-
graphic data). In particular, ICE had greater sensitivity for
detecting small ICM localized in cardiac areas that are not
easily scanned from TEE, such as the atrio-ventricular part
of the right ventricular lead and the tricuspid valve. These
results could be explained by the major resolution power of
the intracardiac probe (9 MHz vs. 5 MHz) and its shorter
distance from the leads and the tricuspid valve, as well as by
the chance to freely orient the probe in any direction within
M assessed by ICE in patients with ICM at ICE and negative TEE (ICE/TEE– group)
gures 1 and 2. See also Online Videos 3A, 3B, 3C, and 3D.th of IC
s in Fithe heart. Moreover, in patients with a diagnosis of ICM
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but revealed larger sizes of the ICM themselves.
An important issue is the lack of a gold standard to confirm
the diagnosis of IE (e.g., a tissue specimen). Considering TEE
as a gold standard, ICE has a high sensitivity (100%) but a
lower specificity (82.8%). A false-positive diagnosis of IE
might occur in several situations; for example, it may be
difficult to differentiate between IE and thrombi, prolapsed
cusp, cardiac tumors, myxomatous changes, Lambl’s excres-
cences, strands, or noninfective vegetations (marantic endocar-
ditis) (9–14). Moreover, a recent study reported that ICE also
identified ICM in patients undergoing ablation without an
infective process (21). However, even though it cannot be
completely proven that all apparent ICM are really of infec-
tious origin, the combination of ICE data, modified Duke and
Sohail criteria, and microbiological data allow us to feel
confident in considering most ICM as infective.
Furthermore, Bongiorni et al. (22) first described the
potential applications of ICE during lead extraction proce-
dures, reporting that ICE was helpful both in evaluating the
procedural risk stratification (localization of cardiac leads
and fibrous adherences, relationship of leads with venous
wall and cardiac structures, and presence of thrombosis or
lead endocarditis) and in the identification of procedure-
related complications (vessel or cardiac wall tear). Com-
pared with this study in which a mechanical rotational probe
was used, our study used a phased array technology echo
probe, which has more advantages in terms of resolution
and deeper penetration and thus allows better assessment of
all cardiac structures. Furthermore, our study demonstrated
that ICE was helpful not only for the procedural risk
stratification and the identification of procedure-related
complications, but it was also a valuable tool for the
diagnosis of device-related IE.
In the scientific literature, only a few case reports have
assessed the role of ICE in detecting intracardiac vegeta-
tions (16,19–21). Our data suggest that, because small ICM
(especially involving cardiac devices) may be difficult to
diagnose with TEE, when the clinical suspicion of IE is
high, ICE may be a valuable tool in confirming or rejecting
the diagnosis of ICM. Furthermore, its greater cost and
invasiveness compared with TEE could be justified, espe-
cially if we consider that reported mortality rates of cardiac
device–related endocarditis range from 31% to 66% if the
infected device is not removed, and 18% or less with a
combined approach consisting of complete device removal
and antimicrobial therapy (5,9,10).
Study limitations. The main limitation of this study is the
lack of a gold standard (e.g., a tissue specimen) to confirm
diagnosis of IE. Moreover, we did not perform an outcome or
a cost-effective analysis of ICE; however, the use of ICE
during lead extraction procedures can also be justified by safety
reasons while performing such an invasive and potentially
dangerous procedure, as stated by other authors (22).Conclusions
In patients with a clinical suspicion of cardiovascular im-
plantable electronic device–related IE undergoing trans-
venous lead extraction, ICE showed a higher diagnostic
power in detecting ICM suggestive of vegetations compared
with TEE. ICE may be a valuable tool in confirming or
rejecting the diagnosis of device-related IE in patients with
high clinical suspicion of IE and a negative result on TEE.
Further investigations are needed to assess the role of
ICE in the clinical outcome of these patients and the
cost-effectiveness of this new tool.
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